APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucagon

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Selected research

Industry Growth & Trends

Global Glucagon Industry Growth and Trends Forecast to 2032

21 December 202592 pages

Choose your research edition.

Industry ResearchGlucagon Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucagon Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Glucagon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucagon Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucagon Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Glucagon market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glucagon market size, estimates, and forecasts are presented in terms of sales volume (K MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glucagon market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glucagon.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glucagon market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glucagon Market by Company

Novo Nordisk

Eli Lilly

Fresenius Kabi

Torrent Labs

Taj Pharmaceuticals

Xeris Pharmaceuticals

Glucagon Segment by Type

Inject Glucagon

Nasal Glucagon

Glucagon Segment by Application

Emergency Kits

General Use

Diagnostic & Motility

Cardiogenic Shock

Others

Glucagon Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucagon and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glucagon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inject Glucagon Table 2. Major Company of Nasal Glucagon Table 3. Global Glucagon Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Glucagon Sales by Type (2021-2026) & (K MT) Table 5. Global Glucagon Sales Market Share in Volume by Type (2021-2026) Table 6. Global Glucagon Sales by Type (2021-2026) & (US$ Million) Table 7. Global Glucagon Sales Market Share in Value by Type (2021-2026) Table 8. Global Glucagon Price by Type (2021-2026) & (USD/MT) Table 9. Global Glucagon Sales by Type (2027-2032) & (K MT) Table 10. Global Glucagon Sales Market Share in Volume by Type (2027-2032) Table 11. Global Glucagon Sales by Type (2027-2032) & (US$ Million) Table 12. Global Glucagon Sales Market Share in Value by Type (2027-2032) Table 13. Global Glucagon Price by Type (2027-2032) & (USD/MT) Table 14. North America Glucagon Sales by Type (2021-2026) & (K MT) Table 15. North America Glucagon Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Glucagon Sales by Type (2021-2026) & (K MT) Table 17. Europe Glucagon Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Glucagon Sales by Type (2021-2026) & (K MT) Table 19. Asia-Pacific Glucagon Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Glucagon Sales by Type (2021-2026) & (K MT) Table 21. Latin America Glucagon Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Glucagon Sales by Type (2021-2026) & (K MT) Table 23. Middle East and Africa Glucagon Sales by Type (2021-2026) & (US$ Million) Table 24. Glucagon Industry Trends Table 25. Glucagon Industry Drivers Table 26. Glucagon Industry Opportunities and Challenges Table 27. Glucagon Industry Restraints Table 28. Global Glucagon Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Glucagon Revenue Market Share by Company (2021-2026) Table 30. Global Glucagon Sales by Company (2021-2026) & (K MT) Table 31. Global Glucagon Sales Share by Company (2021-2026) Table 32. Global Glucagon Market Price by Company (2021-2026) & (USD/MT) Table 33. Global Glucagon Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Glucagon Major Company Production Sites and Headquarters Table 35. Global Glucagon Company, Product Type & Application Table 36. Global Glucagon Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Glucagon by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Glucagon Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Glucagon Sales by Region (2021-2026) & (K MT) Table 41. Global Glucagon Sales Market Share in Volume by Region (2021-2026) Table 42. Global Glucagon Sales by Region (2021-2026) & (US$ Million) Table 43. Global Glucagon Sales Market Share in Value by Region (2021-2026) Table 44. Global Glucagon Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 45. Global Glucagon Sales by Region (2027-2032) & (K MT) Table 46. Global Glucagon Sales Market Share in Volume by Region (2027-2032) Table 47. Global Glucagon Sales by Region (2027-2032) & (US$ Million) Table 48. Global Glucagon Sales Market Share in Value by Region (2027-2032) Table 49. Global Glucagon Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2027-2032) Table 50. Global Glucagon Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Glucagon Sales by Application (2021-2026) & (K MT) Table 52. Global Glucagon Sales Market Share in Volume by Application (2021-2026) Table 53. Global Glucagon Sales by Application (2021-2026) & (US$ Million) Table 54. Global Glucagon Sales Market Share in Value by Application (2021-2026) Table 55. Global Glucagon Price by Application (2021-2026) & (USD/MT) Table 56. Global Glucagon Sales by Application (2027-2032) & (K MT) Table 57. Global Glucagon Sales Market Share in Volume by Application (2027-2032) Table 58. Global Glucagon Sales by Application (2027-2032) & (US$ Million) Table 59. Global Glucagon Sales Market Share in Value by Application (2027-2032) Table 60. Global Glucagon Price by Application (2027-2032) & (USD/MT) Table 61. North America Glucagon Sales by Application (2021-2026) & (K MT) Table 62. North America Glucagon Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Glucagon Sales by Application (2021-2026) & (K MT) Table 64. Europe Glucagon Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Glucagon Sales by Application (2021-2026) & (K MT) Table 66. Asia-Pacific Glucagon Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Glucagon Sales by Application (2021-2026) & (K MT) Table 68. Latin America Glucagon Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Glucagon Sales by Application (2021-2026) & (K MT) Table 70. Middle East and Africa Glucagon Sales by Application (2021-2026) & (US$ Million) Table 71. Novo Nordisk Company Information Table 72. Novo Nordisk Business Overview Table 73. Novo Nordisk Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 74. Novo Nordisk Glucagon Product Portfolio Table 75. Novo Nordisk Recent Development Table 76. Eli Lilly Company Information Table 77. Eli Lilly Business Overview Table 78. Eli Lilly Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 79. Eli Lilly Glucagon Product Portfolio Table 80. Eli Lilly Recent Development Table 81. Fresenius Kabi Company Information Table 82. Fresenius Kabi Business Overview Table 83. Fresenius Kabi Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 84. Fresenius Kabi Glucagon Product Portfolio Table 85. Fresenius Kabi Recent Development Table 86. Torrent Labs Company Information Table 87. Torrent Labs Business Overview Table 88. Torrent Labs Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 89. Torrent Labs Glucagon Product Portfolio Table 90. Torrent Labs Recent Development Table 91. Taj Pharmaceuticals Company Information Table 92. Taj Pharmaceuticals Business Overview Table 93. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 94. Taj Pharmaceuticals Glucagon Product Portfolio Table 95. Taj Pharmaceuticals Recent Development Table 96. Xeris Pharmaceuticals Company Information Table 97. Xeris Pharmaceuticals Business Overview Table 98. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 99. Xeris Pharmaceuticals Glucagon Product Portfolio Table 100. Xeris Pharmaceuticals Recent Development Table 101. North America Glucagon Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 102. North America Glucagon Sales by Country (2021-2026) & (K MT) Table 103. North America Glucagon Sales Market Share by Country (2021-2026) Table 104. North America Glucagon Sales Forecast by Country (2027-2032) & (K MT) Table 105. North America Glucagon Sales Market Share Forecast by Country (2027-2032) Table 106. North America Glucagon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Glucagon Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Glucagon Market Share by Country (2021-2026) Table 109. North America Glucagon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Glucagon Market Share Forecast by Country (2027-2032) Table 111. Europe Glucagon Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 112. Europe Glucagon Sales by Country (2021-2026) & (K MT) Table 113. Europe Glucagon Sales Market Share by Country (2021-2026) Table 114. Europe Glucagon Sales Forecast by Country (2027-2032) & (K MT) Table 115. Europe Glucagon Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Glucagon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Glucagon Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Glucagon Market Share by Country (2021-2026) Table 119. Europe Glucagon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Glucagon Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Glucagon Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Glucagon Sales by Country (2021-2026) & (K MT) Table 123. Asia-Pacific Glucagon Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Glucagon Sales Forecast by Country (2027-2032) & (K MT) Table 125. Asia-Pacific Glucagon Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Glucagon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Glucagon Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Glucagon Market Share by Country (2021-2026) Table 129. Asia-Pacific Glucagon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Glucagon Market Share Forecast by Country (2027-2032) Table 131. Latin America Glucagon Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 132. Latin America Glucagon Sales by Country (2021-2026) & (K MT) Table 133. Latin America Glucagon Sales Market Share by Country (2021-2026) Table 134. Latin America Glucagon Sales Forecast by Country (2027-2032) & (K MT) Table 135. Latin America Glucagon Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Glucagon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Glucagon Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Glucagon Market Share by Country (2021-2026) Table 139. Latin America Glucagon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Glucagon Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Glucagon Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Glucagon Sales by Country (2021-2026) & (K MT) Table 143. Middle East and Africa Glucagon Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Glucagon Sales Forecast by Country (2027-2032) & (K MT) Table 145. Middle East and Africa Glucagon Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Glucagon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Glucagon Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Glucagon Market Share by Country (2021-2026) Table 149. Middle East and Africa Glucagon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Glucagon Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Glucagon Distributors List Table 154. Glucagon Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Glucagon Image Figure 2. Global Glucagon Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucagon Market Size (2021-2032) & (US$ Million) Figure 4. Global Glucagon Sales (2021-2032) & (K MT) Figure 5. Inject Glucagon Image Figure 6. Global Inject Glucagon Sales YoY Growth (2021-2032) & (K MT) Figure 7. Nasal Glucagon Image Figure 8. Global Nasal Glucagon Sales YoY Growth (2021-2032) & (K MT) Figure 9. Global Glucagon Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Glucagon Market Share by Type 2025 VS 2032 Figure 11. North America Glucagon Sales Market Share in Volume by Type in 2025 Figure 12. North America Glucagon Sales Market Share in Value by Type in 2025 Figure 13. Europe Glucagon Sales Market Share in Volume by Type in 2025 Figure 14. Europe Glucagon Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Glucagon Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Glucagon Sales Market Share in Value by Type in 2025 Figure 17. Latin America Glucagon Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Glucagon Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Glucagon Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Glucagon Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Glucagon Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Emergency Kits Image Figure 24. Global Emergency Kits Sales YoY Growth (2021-2032) & (K MT) Figure 25. General Use Image Figure 26. Global General Use Sales YoY Growth (2021-2032) & (K MT) Figure 27. Diagnostic & Motility Image Figure 28. Global Diagnostic & Motility Sales YoY Growth (2021-2032) & (K MT) Figure 29. Cardiogenic Shock Image Figure 30. Global Cardiogenic Shock Sales YoY Growth (2021-2032) & (K MT) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K MT) Figure 33. Global Glucagon Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Glucagon Market Share by Application 2025 VS 2032 Figure 35. North America Glucagon Sales Market Share in Volume by Application in 2025 Figure 36. North America Glucagon Sales Market Share in Value by Application in 2025 Figure 37. Europe Glucagon Sales Market Share in Volume by Application in 2025 Figure 38. Europe Glucagon Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Glucagon Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Glucagon Sales Market Share in Value by Application in 2025 Figure 41. Latin America Glucagon Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Glucagon Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Glucagon Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Glucagon Sales Market Share in Value by Application in 2025 Figure 45. North America Glucagon Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 46. North America Glucagon Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Glucagon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Glucagon Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Glucagon Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 50. Europe Glucagon Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Glucagon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Glucagon Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Glucagon Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 54. Asia-Pacific Glucagon Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Glucagon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Glucagon Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Glucagon Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 58. Latin America Glucagon Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Glucagon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Glucagon Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Glucagon Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 62. Middle East and Africa Glucagon Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Glucagon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Glucagon Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Glucagon Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Glucagon Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Inject Glucagon
  • Nasal Glucagon
Applications
  • Emergency Kits
  • General Use
  • Diagnostic & Motility
  • Cardiogenic Shock
  • Others
Companies covered
  • Novo Nordisk
  • Eli Lilly
  • Fresenius Kabi
  • Torrent Labs
  • Taj Pharmaceuticals
  • Xeris Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucagon Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glucagon Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glucagon Market by Type
  6. 1.3.1 Inject Glucagon
  7. 1.3.2 Nasal Glucagon
  8. 1.4 Global Glucagon Market Size by Type
  9. 1.4.1 Global Glucagon Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Glucagon Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Glucagon Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Glucagon Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Glucagon Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Glucagon Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Glucagon Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Glucagon Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glucagon Industry Trends
  2. 2.2 Glucagon Industry Drivers
  3. 2.3 Glucagon Industry Opportunities and Challenges
  4. 2.4 Glucagon Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glucagon Revenue (2021-2026)
  2. 3.2 Global Top Players by Glucagon Sales (2021-2026)
  3. 3.3 Global Top Players by Glucagon Price (2021-2026)
  4. 3.4 Global Glucagon Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glucagon Major Company Production Sites & Headquarters
  6. 3.6 Global Glucagon Company, Product Type & Application
  7. 3.7 Global Glucagon Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glucagon Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glucagon Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glucagon Tier 1, Tier 2, and Tier 3
4 Glucagon Regional Status and Outlook
  1. 4.1 Global Glucagon Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glucagon Historic Market Size by Region
  3. 4.2.1 Global Glucagon Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glucagon Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glucagon Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glucagon Forecasted Market Size by Region
  7. 4.3.1 Global Glucagon Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glucagon Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glucagon Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glucagon by Application
  1. 5.1 Glucagon Market by Application
  2. 5.1.1 Emergency Kits
  3. 5.1.2 General Use
  4. 5.1.3 Diagnostic & Motility
  5. 5.1.4 Cardiogenic Shock
  6. 5.1.5 Others
  7. 5.2 Global Glucagon Market Size by Application
  8. 5.2.1 Global Glucagon Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Glucagon Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Glucagon Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Glucagon Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Glucagon Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Glucagon Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Glucagon Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Glucagon Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novo Nordisk
  2. 6.1.1 Novo Nordisk Company Information
  3. 6.1.2 Novo Nordisk Business Overview
  4. 6.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novo Nordisk Glucagon Product Portfolio
  6. 6.1.5 Novo Nordisk Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly Glucagon Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
  13. 6.3 Fresenius Kabi
  14. 6.3.1 Fresenius Kabi Company Information
  15. 6.3.2 Fresenius Kabi Business Overview
  16. 6.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fresenius Kabi Glucagon Product Portfolio
  18. 6.3.5 Fresenius Kabi Recent Developments
  19. 6.4 Torrent Labs
  20. 6.4.1 Torrent Labs Company Information
  21. 6.4.2 Torrent Labs Business Overview
  22. 6.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Torrent Labs Glucagon Product Portfolio
  24. 6.4.5 Torrent Labs Recent Developments
  25. 6.5 Taj Pharmaceuticals
  26. 6.5.1 Taj Pharmaceuticals Company Information
  27. 6.5.2 Taj Pharmaceuticals Business Overview
  28. 6.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
  30. 6.5.5 Taj Pharmaceuticals Recent Developments
  31. 6.6 Xeris Pharmaceuticals
  32. 6.6.1 Xeris Pharmaceuticals Company Information
  33. 6.6.2 Xeris Pharmaceuticals Business Overview
  34. 6.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
  36. 6.6.5 Xeris Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Glucagon Sales by Country
  2. 7.1.1 North America Glucagon Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glucagon Sales by Country (2021-2026)
  4. 7.1.3 North America Glucagon Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glucagon Market Size by Country
  6. 7.2.1 North America Glucagon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glucagon Market Size by Country (2021-2026)
  8. 7.2.3 North America Glucagon Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glucagon Sales by Country
  2. 8.1.1 Europe Glucagon Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glucagon Sales by Country (2021-2026)
  4. 8.1.3 Europe Glucagon Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glucagon Market Size by Country
  6. 8.2.1 Europe Glucagon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glucagon Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glucagon Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glucagon Sales by Country
  2. 9.1.1 Asia-Pacific Glucagon Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glucagon Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glucagon Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glucagon Market Size by Country
  6. 9.2.1 Asia-Pacific Glucagon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glucagon Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glucagon Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glucagon Sales by Country
  2. 10.1.1 South America Glucagon Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glucagon Sales by Country (2021-2026)
  4. 10.1.3 South America Glucagon Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glucagon Market Size by Country
  6. 10.2.1 South America Glucagon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glucagon Market Size by Country (2021-2026)
  8. 10.2.3 South America Glucagon Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glucagon Sales by Country
  2. 11.1.1 Middle East and Africa Glucagon Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glucagon Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glucagon Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glucagon Market Size by Country
  6. 11.2.1 Middle East and Africa Glucagon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glucagon Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glucagon Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glucagon Value Chain Analysis
  2. 12.1.1 Glucagon Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glucagon Production Mode & Process
  7. 12.2 Glucagon Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glucagon Distributors
  10. 12.2.3 Glucagon Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst